(Total Views: 214)
Posted On: 05/02/2019 10:42:40 PM
Post# of 154914
What I understood is that they have $50 million (based on $120,000 per patient per year) of commercial grade.....so a little over 400 patients for an entire year.
They have stated $200M total inventory several times, but in a couple recent interviews they have stated only $50M of this was commercial grade (I think one interview stated P3 and commercial grade)...and today NP stated with 525mg they have $62M.....so I interpret this as they have $50M commercial grade of 700mg and another $12M 525mg commercial grade. I suspect the remaining inventory is for current and future P2 trials.
They have stated $200M total inventory several times, but in a couple recent interviews they have stated only $50M of this was commercial grade (I think one interview stated P3 and commercial grade)...and today NP stated with 525mg they have $62M.....so I interpret this as they have $50M commercial grade of 700mg and another $12M 525mg commercial grade. I suspect the remaining inventory is for current and future P2 trials.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
